Quantification of amyloid beta and tau PET without a structural MRI
Alzheimer's & Dementia · 2023-02 · 19 (2) · 444-455
DOI: 10.1002/alz.12668 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 16.04.2022. Verfasst von Susan M Landau und 9 weiteren Autor:innen. Beteiligte Einrichtung: Helen Wills Neuroscience Institute, University of California Berkeley, Berkeley, California, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: NIA NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Introduction
Relying on magnetic resonance imaging (MRI) for quantification of positron emission tomography (PET) images may limit generalizability of the results. We evaluated several MRI‐free approaches for amyloid beta (Aβ) and tau PET quantification relative to MRI‐dependent quantification cross‐sectionally and longitudinally.
Methods
We compared baseline MRI‐free and MRI‐dependent measurements of Aβ PET ([18F]florbetapir [FBP], N = 1290, [18F]florbetaben [FBB], N = 290) and tau PET ([18F]flortaucipir [FTP], N = 768) images with respect to continuous and dichotomous agreement, effect sizes of Aβ+ impaired versus Aβ– unimpaired groups, and longitudinal standardized uptake value ratio (SUVR) slopes in a subset of individuals.
Results
The best‐performing MRI‐free approaches had high continuous and dichotomous agreement with MRI‐dependent SUVRs for Aβ PET and temporal flortaucipir (R 2 ≥0.95; ± agreement ≥92%) and for Alzheimer's disease–related effect sizes; agreement was slightly lower for entorhinal flortaucipir and longitudinal slopes.
Discussion
There is no consistent loss of baseline or longitudinal AD‐related signal with MRI‐free Aβ and tau PET image quantification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Helen Wills Neuroscience Institute, University of California Berkeley, Berkeley, California, USA.
- Memory and Aging Center, University of California, San Francisco, California, USA.
- Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, California, USA.
- Division of Nuclear Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Förderung
- NIA NIH HHS
- National Institutes of Health
Zitieren
APA
Landau, S. M., Ward, T. J., Murphy, A., Iaccarino, L., Harrison, T. M., La Joie, R., Baker, S., Koeppe, R. A., Jagust, W. J., & Alzheimer's Disease Neuroimaging Initiative (2023). Quantification of amyloid beta and tau PET without a structural MRI. Alzheimer's & Dementia, 19(2), 444-455. https://doi.org/10.1002/alz.12668
Vancouver
Landau SM, Ward TJ, Murphy A, Iaccarino L, Harrison TM, La Joie R, et al. Quantification of amyloid beta and tau PET without a structural MRI. Alzheimer's & Dementia. 2023;19(2):444-455. doi:10.1002/alz.12668
BibTeX
@article{Landau2023,
author = {Landau, Susan M and Ward, Tyler J and Murphy, Alice and Iaccarino, Leonardo and Harrison, Theresa M and La Joie, Renaud and Baker, Suzanne and Koeppe, Robert A and Jagust, William J and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Quantification of amyloid beta and tau PET without a structural MRI},
journal = {Alzheimer's & Dementia},
year = {2023},
volume = {19},
number = {2},
pages = {444--455},
doi = {10.1002/alz.12668}
}
EUVIMED